title: Leptin acts independently of food intake to modulate gut microbial composition in male mice.
abstract: Shifts in the composition of gut bacterial populations can alter host metabolism and may contribute to the pathogenesis of metabolic disorders, including obesity. Mice deficient in leptin action are obese with altered microbiota and increased susceptibility to certain intestinal pathogens. Because antimicrobial peptides (AMPs) secreted by Paneth cells represent a major mechanism by which the host influences the gut microbiome, we examined the mRNA expression of gut AMPs, several of which were decreased in leptin receptor (LepR)-deficient db/db mice, suggesting a potential role for AMP modulation of microbiota composition. To address the extent to which the alterations in gut microbiota and AMP mRNA expression in db/db mice result from increased food intake vs other defects in leptin action, we examined the effects of pair feeding and gut epithelial LepRb ablation on AMP mRNA expression and microbiota composition. We found that the phylum-level changes in fecal microbial content and AMP gene expression persist in pair-fed db/db mice, suggesting that these differences do not stem from hyperphagia alone. In addition, despite recent evidence to support a role for intestinal epithelial LepRb signaling in pathogen susceptibility, ablation of LepRb from the intestinal epithelium fails to alter body weight, composition of the microbiota, or AMP expression, suggesting a role for LepRb elsewhere for this regulation. Indeed, gut LepRb cells are not epithelial but rather constitute a previously uncharacterized population of perivascular cells within the intestinal submucosa. Overall, our data reveal a role for LepRb signaling extrinsic to the intestinal epithelium and independent of food intake in the control of the gut microbiome.
authors.affiliation: Department of Internal Medicine, Division of Gastroenterology (M.W.R.), Division of Metabolism, Endocrinology and Diabetes (C.M.P., M.G.M.) and Division of Infectious Disease (J.S.O., S.K.F., V.B.Y.). Department of Microbiology and Immunology (V.B.Y.), Department of Molecular and Integrative Physiology (M.G.M.), and Neuroscience Program (M.G.M.), University of Michigan, Ann Arbor, Michigan.
authors.forename: Michael W
authors.initials: MW
authors.lastname: Rajala
authors.forename: Christa M
authors.initials: CM
authors.lastname: Patterson
authors.forename: Judith S
authors.initials: JS
authors.lastname: Opp
authors.forename: Susan K
authors.initials: SK
authors.lastname: Foltin
authors.forename: Vincent B
authors.initials: VB
authors.lastname: Young
authors.forename: Martin G
authors.initials: MG
authors.lastname: Myers
mesh_terms: D000818:Animals; D023181:Antimicrobial Cationic Peptides; D004435:Eating; D004748:Entamoeba histolytica / Q000378:metabolism; D005260:Female; D020869:Gene Expression Profiling; D005786:Gene Expression Regulation; D006963:Hyperphagia; D007150:Immunohistochemistry; D007413:Intestinal Mucosa / Q000378:metabolism*; D007422:Intestines / Q000382:microbiology*; D020738:Leptin / Q000378:metabolism*; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic; D064307:Microbiota; D012333:RNA, Messenger / Q000378:metabolism; D054411:Receptors, Leptin / Q000235:genetics / Q000378:metabolism*; D015398:Signal Transduction
chemical_list: D023181:Antimicrobial Cationic Peptides; D020738:Leptin; D012333:RNA, Messenger; D054411:Receptors, Leptin; C515447:leptin receptor, mouse